


Vermilion Therapeutics Email Formats
Research Services • 2-12-8, Kita-Aoyama, Japan • 1-10 Employees
Key Contact at Vermilion Therapeutics
Shinichi Torii
CEO & President
Company overview
| Headquarters | 2-12-8, Kita-Aoyama, Minato-ku, Tokyo 107-0061 Japan, BIZ SMART Aoyama#332, Minato-ku, Tokyo 107-0061, JP |
| Phone number | +811510051 |
| Website | |
| NAICS | 5417 |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
About Vermilion Therapeutics
1. Dementia/Alzheimer's disease Target disease: Alzheimer's disease 2. Peripheral amyloidosis Target disease: Cardiac / renal amyloidosis 3. New DDS system and therapeutic drug development Target disease: Target disease: Alzheimer's disease 4. Infectious disease Target disease: Infectious disease including Corona-virus (SARS-CoV-2) 5. Cancer immunity-related therapeutics (except PD-1, PD-L1) Target disease: Target disease: Solid cancer
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Vermilion Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Vermilion Therapeutics Tech Stack
Discover the technologies and tools that power Vermilion Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
Tag managers
Reverse proxies
Programming languages
Miscellaneous
Hosting
Blogs
JavaScript libraries
Analytics
Maps
Frequently asked questions
4.8
40,000 users



